PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsmycoplasma infections
MeSH D009175 - mycoplasma infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D009180:Mycoplasmatales infections
0 Companies
0 Drugs
Success rate
D009175: 
Mycoplasma infections
D011002:Contagious pleuropneumonia
0 Companies
0 Drugs
Success rate
D011019:Mycoplasma pneumonia
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaDoxycycline hyclate Doxy-lemmon  1984-06-15   
Levofloxacin Levofloxacin  2011-06-20   
Tetracycline Tetracycline  1982-01-01   
Tetracycline Tetramed  1982-01-01   
Glenmark PharmaceuticalsLevofloxacin Levofloxacin  2011-06-20   
MylanDoxycycline hyclate Doxycycline  2012-08-21   
Doxycycline hyclate Doxycycline Hyclate  1983-02-15   
Levofloxacin Levofloxacin  2011-06-20   
NATCO PharmaLevofloxacin Levofloxacin  2011-06-20   
Mayne GroupDoxycycline hyclate Doryx  1985-07-22   
Doxycycline hyclate Doryx Mpc 2022-12-15 2005-05-06   
Johnson & JohnsonLevofloxacin Levaquin  1996-12-20   
Chartwell PharmaceuticalsDoxycycline hyclate Acticlate  2014-07-25   
Doxycycline hyclate Acticlate Cap  2016-04-26   
Doxycycline Doxycycline  2008-07-16   
Doxycycline hyclate Doxycycline Hyclate  1984-09-11   
Levofloxacin Levofloxacin  2012-03-30   
Doxycycline hyclate Lymepak  2018-06-15   
Doxycycline Monodox  1989-12-29   
Tetracycline Tetracycline  1988-08-12   
1
2
3
4
5
6
...
13
>
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
0%
0/0
Phase 3
100%
11/11
Approved: 9Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Journey Medical
Teva
1
2
3
4
5
6
...
9
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use